MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 25.02.2026
Penumbra Langfristige Verbindlichkeiten 2011-2026 | PEN
Langfristige Verbindlichkeiten Jährlich Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 89.2 M | 26.5 M | 24.7 M | 5.91 M | 3.18 M | 113 M | 63.4 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 113 M | 3.18 M | 46.5 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
1.61 M | $ 34.74 | 0.8 % | $ 1.6 B |  USA |
 |
Align Technology
ALGN
|
184 M | $ 186.13 | 0.78 % | $ 13.9 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 12.68 | -0.74 % | $ 1.71 B | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Inogen
INGN
|
52.5 M | $ 6.3 | -0.71 % | $ 168 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.02 | -0.49 % | $ 17.3 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.35 B | $ 296.27 | 1.31 % | $ 8.36 B | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.41 | 3.28 % | $ 128 M |  France |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 39.67 | -0.59 % | $ 5.91 K | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 64.37 | 0.86 % | $ 95.3 B | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.6 | 1.14 % | $ 37.3 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
LENSAR
LNSR
|
3.44 M | $ 6.19 | 2.48 % | $ 74 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
252 K | $ 1.97 | -0.76 % | $ 1.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 10.47 | 0.82 % | $ 296 M | USA |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Myomo
MYO
|
275 K | $ 0.8 | 0.52 % | $ 33.5 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 25.61 | 1.59 % | $ 217 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.8 | - | $ 7.77 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Smith & Nephew plc
SNN
|
4.04 B | $ 34.23 | -0.35 % | $ 23.8 B |  Britain |
 |
Globus Medical
GMED
|
18.2 M | $ 94.71 | -0.24 % | $ 12.8 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 18.07 | 1.18 % | $ 424 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Tactile Systems Technology
TCMD
|
14.1 M | $ 25.33 | 1.08 % | $ 579 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
2.52 M | $ 10.9 | 0.18 % | $ 390 M | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 21.13 | 0.09 % | $ 1.44 B | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 57.54 | 1.25 % | $ 1.69 B | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 39.18 | -1.38 % | $ 1.22 B | USA |
 |
LivaNova PLC
LIVN
|
516 M | $ 65.53 | 0.82 % | $ 3.57 B | Britain |